Physician profile
Sam William Levine
NPI 1528007127
$5,031.69
in general payments reported to CMS, 2019-2025
8 companies · $911 in 2025
The $911 reported for 2025 was more than what 88% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $137 · 2021: $488 · 2022: $910 · 2023: $834 · 2024: $892 · 2025: $911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,637.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,091.33 | 2019-2025 | Invisalign, Vivera Retainers, Invisalign Retainer |
| Envista Holdings Corporation | $1,300.39 | 2024-2025 | Spark, Damon, Damon 3 |
| Ormco Corporation | $995.91 | 2021-2023 | Spark, Damon, Red, White and Blue Retainer |
| Nobel Biocare USA | $220.14 | 2023 | Nobelactive |
| Ortho Organizers, INC. | $119.51 | 2023 | Carriere |
| Lightforce Orthodontics, INC. | $103.69 | 2024 | |
| Solventum Corporation | $100.45 | 2025 | Clarity Aligners |
| American Orthodontics Corporation | $100.27 | 2023 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.